• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
Displaying 54-68 of 253,058 results

Yeda Research and Development v. Mylan Pharmaceuticals Inc.

Docket 17-1595, U.S. Court of Appeals, Federal Circuit (Feb. 8, 2017)
Appellant YEDA RESEARCH AND DEVELOPMENT CO., LTD.
Appellee MYLAN PHARMACEUTICALS INC.
Appellee AMNEAL PHARMACEUTICALS LLC
cite Cite Docket
Analyze

No. 24 ORDER filed denying the motion for an extension of time, ECF No. [20]; Bausch's response brief ...

Document Mylan Pharmaceuticals Inc. v. Bausch Health Ireland Ltd., 24-1011, No. 24 (Fed. Cir. Feb. 16, 2024)
Motion to Extend TimeDenied
United States Court of Appeals for the Federal Circuit
Bausch Health Ireland Ltd. moves for an extension of time, until May 6, 2024, to file its response brief, currently due March 11, 2024.
Mylan Pharmaceuticals Inc. re- sponds, arguing that the court should expedite oral MYLAN PHARMACEUTICALS INC. v. BAUSCH HEALTH IRELAND 2
Bausch argues that the requested extension is neces- sary due to unspecified deadlines in district court litiga- tions in February and March.
(2) The motion to expedite oral argument, ECF No. 21, is denied as moot.
cite Cite Document
Analyze

Altaire Pharmaceuticals, Inc. v. Paragon Bioteck, Inc.

Docket 17-1487, U.S. Court of Appeals, Federal Circuit (Jan. 17, 2017)
Appellant ALTAIRE PHARMACEUTICALS, INC.
Appellee PARAGON BIOTECK, INC.
Altaire Pharmaceuticals, Inc.
...
cite Cite Docket
Analyze

Worlds Inc. v. Bungie, Inc.

Docket 17-1481, U.S. Court of Appeals, Federal Circuit (Jan. 13, 2017)
Appellant WORLDS INC.
Appellee BUNGIE, INC.
cite Cite Docket
Analyze

Palette Life Sciences, Inc. v. Incept LLC

Docket IPR2020-00002, Patent Trial and Appeal Board (Oct. 14, 2019)

cite Cite Docket
Analyze

Palette Life Sciences, Inc. v. Incept LLC

Docket IPR2020-00003, Patent Trial and Appeal Board (Oct. 14, 2019)

cite Cite Docket
Analyze

Palette Life Sciences, Inc. v. Incept LLC

Docket IPR2020-00004, Patent Trial and Appeal Board (Oct. 14, 2019)

cite Cite Docket
Analyze

Palette Life Sciences, Inc. v. Incept LLC

Docket IPR2020-00005, Patent Trial and Appeal Board (Oct. 14, 2019)

cite Cite Docket
Analyze

Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH

Docket IPR2019-01658, Patent Trial and Appeal Board (Oct. 7, 2019)

cite Cite Docket
Analyze

Mylan Pharmaceuticals Inc. v. Sanfoi-Aventis Deutschland GmbH

Docket IPR2019-01657, Patent Trial and Appeal Board (Oct. 7, 2019)

cite Cite Docket
Analyze

No. Order-09-14-23

Document Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd., 23-1540 (Fed. Cir. Sep. 14, 2023)

cite Cite Document
Analyze

Droplets, Inc. v. ETRADE Bank

Docket 16-2504, U.S. Court of Appeals, Federal Circuit (Aug. 18, 2016)

cite Cite Docket
Analyze

Aquestive Therapeutics, Inc. formerly Monosol RX, LLC v. Neurelis, Inc.

Docket IPR2019-00450, Patent Trial and Appeal Board (Jan. 29, 2019)

cite Cite Docket
Analyze

Aquestive Therapeutics, Inc. formerly Monosol RX, LLC v. Neurelis, Inc.

Docket IPR2019-00451, Patent Trial and Appeal Board (Jan. 29, 2019)

cite Cite Docket
Analyze

Aquestive Therapeutics, Inc. formerly Monosol RX, LLC v. Neurelis, Inc.

Docket IPR2019-00449, Patent Trial and Appeal Board (Jan. 28, 2019)

cite Cite Docket
Analyze
<< 1 2 3 4 5 6 7 8 ... >>